Full Paper
766, 733 cm–1. HRMS (ESI): calcd. for C26H27N2OS+ 415.1844; found
415.1809.
Diastereomer 1: M.p. 128.8–130.7 °C. 1H NMR (500 MHz, CDCl3):
δ = 7.10–7.08 (m, 3 H), 7.06–7.04 (m, 2 H), 6.83–6.69 (m, 2 H), 6.57
(d, J = 7.5 Hz, 2 H), 6.47 (s, 1 H), 5.67 (s, 1 H), 4.14 (ddd, J = 13.5,
8.0, 8.0 Hz, 1 H), 3.79 (s, 3 H), 3.66 (s, 3 H), 2.75 (ddd, J = 14.5, 7.5,
5.5 Hz, 1 H), 1.54–1.50 (m, 2 H), 1.32–1.23 (m, 2 H), 0.89 (t, J = 7.5 Hz,
3 H) ppm. 13C NMR (125 MHz, CDCl3): δ = 182.7 (C), 172.0 (C), 159.6
(C), 134.5 (C), 128.5 (n CH), 128.5 (n CH), 125.9 (n CH), 125.4 (C),
113.7 (n CH), 73.0 (C), 70.1 (CH), 55.3 (CH3), 53.7 (CH3), 45.0 (CH2),
1′,5′-Dibutylspiro[fluorene-9,4′-imidazolidine]-2′-thione (4c5d):
According to general procedure 2, the reaction between n-butyl-
amine (99 μL, 1.00 mmol), valeraldehyde (117 μL, 1.10 mmol) and
9-isothiocyanato-9H-fluorene (4c; 112 mg, 0.50 mmol) afforded
1
4c5d as a white solid (53 mg, 23 %). M.p. 125.1–125.6 °C. H NMR
(500 MHz, CDCl3): δ = 7.64 (t, J = 8.0 Hz, 2 H), 7.55 (d, J = 7.5 Hz, 1
H), 7.47 (d, J = 7.5 Hz, 1 H), 7.43–7.40 (m, 2 H), 7.34 (td, J = 7.5,
0.5 Hz, 1 H), 7.28 (td, J = 7.0, 0.5 Hz, 1 H), 5.74 (s, 1 H), 4.25 (dd, J =
10.5, 4.0 Hz, 1 H), 4.04 (ddd, J = 14.5, 9.5, 6.5 Hz, 1 H), 3.50 (ddd,
J = 12.5, 9.5, 7.0 Hz, 1 H), 1.69–1.61 (m, 2 H), 1.47–1.43 (m, 2 H),
1.34–1.28 (m, 1 H), 1.01 (t, J = 7.0 Hz, 3 H), 0.93–0.81 (m, 3 H), 0.65–
0.57 (m, 1 H), 0.45 (t, J = 7.5 Hz, 3 H), 0.44–0.38 (m, 1 H) ppm. 13C
NMR (125 MHz, CDCl3): δ = 183.9 (C), 145.7 (C), 143.3 (C), 140.5 (C),
140.1 (C), 130.0 (CH), 129.9 (CH), 128.4 (CH), 128.2 (CH), 125.6 (CH),
124.5 (CH), 120.5 (CH), 120.3 (CH), 72.2 (C), 68.2 (CH), 44.9 (CH2),
29.3 (CH2), 28.5 (CH2), 26.8 (CH2), 22.2 (CH2), 20.4 (CH2), 14.1 (CH3),
29.1 (CH2), 19.9 (CH2), 13.9 (CH3) ppm. IR (neat): νmax = 3175, 2959,
˜
1730, 1608, 1508, 1448, 1231, 1205, 1038, 932, 827, 692 cm–1. HRMS
(ESI): calcd. for C22H27N2O3S+ 399.1737; found 399.1729.
1
Diastereomer 2: H NMR (500 MHz, CDCl3): δ = 7.64 (d, J = 7.5 Hz,
2 H), 7.45–7.38 (m, 3 H), 7.21 (d, J = 8.5 Hz, 2 H), 6.90 (d, J = 8.5 Hz,
2 H), 6.76 (s, 1 H), 4.98 (s, 1 H), 4.05 (ddd, J = 14.0, 8.0, 8.0 Hz, 1 H),
3.82 (s, 3 H), 3.33 (s, 3 H), 2.67 (ddd, J = 13.5, 8.0, 6.0 Hz, 1 H), 1.34–
1.25 (m, 2 H), 1.05–1.01 (m, 2 H), 0.73 (t, J = 7.0 Hz, 3 H) ppm. 13C
NMR (125 MHz, CDCl3): δ = 181.6 (C), 168.6 (C), 160.3 (C), 140.1 (C),
129.1 (n CH), 129.0 (n CH), 127.0 (C), 125.5 (n CH), 114.3 (n CH), 74.7
(CH), 72.8 (C), 55.4 (CH3), 52.8 (CH3), 44.3 (CH2), 29.3 (CH2), 19.6
13.4 (CH3) ppm. IR (neat): νmax = 3163, 2954, 2925, 2858, 1489, 1448,
˜
1191, 732 cm–1. HRMS (ESI): calcd. for C23H29N2S+ 365.2046; found
365.2028.
(CH2), 13.7 (CH3) ppm. IR (neatνmax = 3190, 2955, 1742, 1610, 1512,
˜
1445, 1246, 1177, 1030, 733, 696 cm–1. HRMS (ESI): calcd. for
C22H27N2O3S+ 399.1737; found 399.1729.
4-(1′-Butyl-2′-thioxospiro[fluorene-9,4′-imidazolidin]-5′-yl)-
benzonitrile (4c5e): According to general procedure 2, the reaction
between n-butylamine (99 μL, 1.00 mmol), p-cyanobenzaldehyde
(144 mg, 1.10 mmol) and 9-isothiocyanato-9H-fluorene (4c; 112 mg,
0.50 mmol) afforded 4c5e as a white solid [20 mg, 10 %; yield based
Methyl 1,5-Dibutyl-4-phenyl-2-thioxoimidazolidine-4-carboxyl-
ate (4e5d): According to general procedure 2, the reaction between
n-butylamine (99 μL, 1.00 mmol), valeraldehyde (117 μL, 1.10 mmol)
and methyl 2-isothiocyanato-2-phenylacetate (4e; 104 mg,
0.50 mmol) afforded 4e5d as a yellow oil (66 mg, 38 %) as a 1:1
1
on H NMR relative to the doublet at δ = 7.97 ppm (4-cyanobenz-
aldehyde, 2 H)]. M.p. 161.3–162.6 °C. 1H NMR (500 MHz, CDCl3): δ =
7.64 (d, J = 7.5 Hz, 1 H), 7.59 (d, J = 7.5 Hz, 1 H), 7.48–7.43 (m, 4 H),
7.22 (t, J = 7.5 Hz, 2 H), 6.93–6.91 (m, 3 H), 6.63 (d, J = 8.0 Hz, 1 H),
6.07 (s, 1 H), 5.17 (s, 1 H), 4.44 (ddd, J = 14.0, 10.0, 6.5 Hz, 1 H), 2.94
(ddd, J = 14.0, 9.5, 5.0 Hz, 1 H), 1.71–1.67 (m, 1 H), 1.55–1.51 (m, 1
H), 1.41–1.31 (m, 2 H), 0.92 (t, J = 7.0 Hz, 3 H) ppm. 13C NMR
(125 MHz, CDCl3): δ = 185.4 (C), 147.2 (C), 141.1 (C), 140.1 (C), 139.8
(C), 139.2 (C), 132.3 (2 CH), 130.2 (CH), 130.0 (CH), 130.0 (CH), 128.8
(CH), 128.3 (CH), 127.5 (CH), 125.9 (CH), 123.3 (CH), 120.5 (CH), 120.3
(CH), 118.4 (C), 112.6 (C), 72.8 (C), 72.8 (CH), 45.6 (CH2), 29.8, 28.8
1
mixture of diastereomers. H NMR (500 MHz, CDCl3): δ = 7.53–7.52
(m, 1 H + 1 H), 7.39–7.34 (m, 4 H + 4 H), 6.62 (s, 1 H), 6.38 (s, 1 H),
4.70–4.68 (m, 1 H), 4.20 (ddd, J = 14.5, 8.5, 7.0 Hz, 1 H), 4.12–4.07
(m, 1 H), 3.75 (s, 3 H), 3.74 (s, 3 H), 3.04 (ddd, J = 14.0, 8.5, 5.0 Hz,
1 H), 2.93 (ddd, J = 14.0, 8.0, 5.0 Hz, 1 H), 2.09–2.06 (m, 1 H), 1.82–
1.77 (m, 1 H), 1.64–1.55 (m, 2 H), 1.01–0.77 (m, 7 H), 0.72 (t, J =
7.0 Hz, 3 H), 0.58 (t, J = 7.5 Hz, 3 H) ppm. 13C NMR (125 MHz, CDCl3):
δ = 182.2 (C), 180.9 (C), 172.4 (C), 169.1 (C), 140.4 (C), 134.1 (C),
129.1 (n CH), 129.1 (n CH), 128.9 (n CH), 126.3 (n CH), 125.1 (n CH),
72.4 (C), 70.6 (CH), 70.3 (C), 65.0 (CH), 53.7 (CH3), 53.1 (CH3), 44.8
(CH2), 44.0 (CH2), 29.4 (CH2), 29.2 (CH2), 29.0 (CH2), 28.1 (CH2), 26.0
(CH2), 25.7 (CH2), 23.0 (CH2), 22.5 (CH2), 20.0 (CH2), 19.5 (CH2), 14.0
(CH2), 20.2 (CH2), 13.9 (CH3) ppm. IR (neat): νmax = 3151, 2230, 1448,
˜
1281, 1188, 1143, 879, 731, 590, 551 cm–1. HRMS (ESI): calcd. for
C26H24N3S+ 410.1685; found 410.1680.
(CH3), 14.0 (CH3), 13.7 (CH3), 13.6 (CH3) ppm. IR (neat): νmax = 2955,
˜
2926, 2856, 1736, 1487, 1431, 1234, 1204, 731, 698 cm–1. HRMS
(ESI): calcd. for C19H29N2O2S+ 349.1944; found 349.1950.
1′,5′-Bis(4-methoxyphenyl)spiro[fluorene-9,4′-imidazolidine]-
2′-thione (4c5f): According to general procedure 2, the reaction
between p-anisidine (123 mg, 1.0 mmol), 4-methoxybenzaldehyde
(828 μL, 6.6 mmol) and 9-isothiocyanato-9H-fluorene (4c; 112 mg,
0.5 mmol) afforded imidazolidine-2-thione 4c5f in trace amounts.
HRMS (ESI): calcd. for C29H24N2NaO2S 487.1451; found 487.1462.
Methyl 1-Butyl-5-(4-cyanophenyl)-4-phenyl-2-thioxoimidazol-
idine-4-carboxylate (4e5e): According to general procedure 2, the
reaction between n-butylamine (99 μL, 1.00 mmol), p-cyanobenz-
aldehyde (144 mg, 1.10 mmol) and methyl (S)-2-isothiocyanato-2-
phenylacetate (4e; 104 mg, 0.50 mmol) afforded 4e5e as a 2:1 mix-
ture of diastereoisomers of which only the minor isomer was fully
5′-Butyl-1′-(4-methoxyphenyl)spiro[fluorene-9,4′-imidazol-
idine]-2′-thione (4c5g): According to general procedure 2, the re-
action between p-anisidine (123 mg, 1.00 mmol), valeraldehyde
(351 μL, 3.30 mmol) and 9-isothiocyanato-9H-fluorene (4c; 112 mg,
0.50 mmol) afforded 4c5g as a yellow oil [41 mg, 20 %; yield based
1
isolated as a red solid (45 mg, 23 %). M.p. 154.6–158.1 °C. H NMR
(500 MHz, CDCl3): δ = 7.36 (d, J = 8.5 Hz, 2 H), 7.12–7.10 (m, 3 H),
7.03–7.02 (m, 4 H), 6.58 (s, 1 H), 5.77 (m, 1 H), 4.21 (ddd, J = 14.0,
8.0, 8.0 Hz, 1 H), 3.82 (s, 3 H), 2.72 (ddd, J = 14.0, 8.0, 6.0 Hz, 1 H),
1.54–1.50 (m, 2 H), 1.31–1.25 (m, 2 H), 0.90 (t, J = 7.5 Hz, 3 H) ppm.
13C NMR (125 MHz, CDCl3): δ = 183.3 (C), 171.4 (C), 139.3 (C), 133.6
(C), 132.1 (CH), 129.5 (CH), 128.8 (2 CH), 125.7 (2 CH), 118.3 (C),
117.9 (CH), 112.5 (C), 73.0 (C), 69.8 (CH), 54.0 (CH3), 45.3 (CH2), 29.1
1
1
on H NMR relative to the doublet at δ = 6.08 ppm (2 H)]. H NMR
(500 MHz, CDCl3): δ = 4.60 (dd, J = 9.5, 4.5 Hz, 1 H) ppm. IR (neat):
νmax = 2926, 1508, 1448, 1437, 1244, 1028, 737 cm–1. HRMS (ESI):
˜
calcd. for C26H27N2OS+ 415.1839; found 415.1825.
Methyl 1-Butyl-5-(4-methoxyphenyl)-4-phenyl-2-thioxoimid-
azolidine-4-carboxylate (4e5c): According to general procedure 2,
the reaction between n-butylamine (99 μL, 1.00 mmol), p-methoxy-
benzaldehyde (144 mg, 1.10 mmol) and methyl (S)-2-isothio-
cyanato-2-phenylacetate (4e; 104 mg, 0.50 mmol) afforded 4e5c as
a yellow solid (diastereomer 1, 68 mg) and a yellow oil (diastereo-
mer 2, 78 mg) (total yield 37 %, dr = 47:53).
(CH2), 19.9 (CH2), 13.9 (CH3) ppm. IR (neat): νmax = 3136, 2955, 2231,
˜
1737, 1481, 1244, 1148, 1059, 842, 689, 550 cm–1. HRMS (ESI): calcd.
for C22H24N3O2S+ 394.1584; found 394.1587.
Methyl 5-Butyl-1-(4-methoxyphenyl)-4-phenyl-2-thioxoimid-
azolidine-4-carboxylate (4e5g): According to general procedure 2,
the reaction between p-anisidine (123 mg, 1.00 mmol), valeralde-
Eur. J. Org. Chem. 0000, 0–0
8
© 0000 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim